IRCT20180720040533N3Completed
The effect of Indian ink on the identification of involved lymph nodes in breast cancer
Preliminary study to evaluate the effectiveness of direct injection of Indian ink and blue methylene in the involved and suspected lymph nodes before and after neoadjuvant chemotherapy in patients with breast cancer and the practical use of this method in detecting theses lymph nodes during surgery.
Tehran University of Medical SciencesIranian Registry Of Clinical Trial
VerifiedIranian Registry Of Clinical Trial
Study focus
- Disease/Condition
- Malignant neoplasm of breast
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Tehran University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- N/A
- Start date
- Apr 21, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedMalignant neoplasm: Central portion of breastPersonal history of malignant neoplasm of breast
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20180720040533N3
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20180720040533N3 through Pure Global AI's free database. This phase not specified trial is sponsored by Tehran University of Medical Sciences and is currently Completed. The study focuses on Malignant neoplasm of breast.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.